Biotech Intelligence for Agile Teams

We track what companies do, not what they say. Trials, regulatory filings, patents, and markets, linked and traceable.

Biotech Industry Intelligence Platform

RxDataLab links regulatory filings to clinical programs and markets, giving you the full picture of who's filing, what trials they're running, and how everything connects. Built for BD, investors, and strategy teams who need traceable data, not commentary.

Explore the Platform →
Clinical trial tracker showing market movements and biotech company data
Mapping the competitive Landscape with clinical trial embeddings

Mapping Competitive Landscapes

Using Form D filings to build a custom fundraising database

Biotech Investment Tracking

Analysis of regulatory impact of FTC Patent challenges

Regulatory Monitoring & Analysis

47,588
FDA-approved drug products
21,155
patent-to-product linkages
24
months of change history

Drug Patent & Exclusivity Data

From $299

Recent Analysis

View all

The Biggest Disclosure Day in Biotech

Brief Report

January 17, 2026

JPM Healthcare opening day triggers more biotech 8-K filings than any other day of the year. Analysis of SEC filing patterns shows 23% of public biotechs tracked by RxDataLab disclose on a single day.

Traceable data for BD, investors, and strategy teams

RxDataLab links regulatory filings to clinical programs and markets, giving you the full picture of who’s filing, what trials they’re running, and how everything connects. Clinical trial records, SEC filings, patent data, and market feeds from primary sources. Traceable data, not commentary.

Ready to Talk?

Whether you're evaluating an investment opportunity, conducting due diligence, preparing for fundraising, or tracking competitive intelligence, We can provide the data and technical depth you need.

Get in Touch
Or email directly at [email protected]